Facial midline malignant syndrome: Histopathological and immunohistochemical aspects of a case;Sindrome maligno-mediofacial: Aspectos histopatologicos e imuno- histoquimicos de um caso

Anais Brasileiros de Dermatologia

Volumn 71, Issue 3, 1996, Pages 229-232

  Dos Santos, Itamar Belo ^c   Da Silva, Mecciene Mendes ^a   Filho, Milton Cunha ^b   Antunes, Consuelo ^b   Lima, Monica Maris ^a  

^a FM/UFPE ^*

^b HOSPITAL BARÃO DE LUCENA   (Brazil)

^c Estrada do Encanamento   (Brazil)

Author keywords

lymphoma, T cell; Wegwner's granulomatosis

Indexed keywords

CYCLOSPORIN; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; MOUTH DISEASE; SEPTICEMIA; T LYMPHOCYTE; WEGENER GRANULOMATOSIS;

EID: 0030058410     PISSN: 03650596     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Abulafia J, Grispan D, Reis AL. Síndrome malígno mediofacial. VII Monografia do Colégio Ibero-Latino-Americano de Dermatologia. 1988;76.
2. Stewart JP. Progressive lethal granulomatous ulceration of the nose. J Laryngol Otol 1933;48(5):657-701.
3. Wegener F. Cutaneous Vasculitis. In: Rook A, Wilkinson, Ebling FJG. Textbook of dermatology. London: Blackwell, 1993.
4. Blat IM, Holbrooke SS, Rubin P et al. Fatal granulomatosis of the respiratory tract (lethal midline granuloma. Wegener's granulomatosis). AMA Arch Otolaryngol 1959;55(6):707-57.
5. Pierini O. Granuloma maligno mediofacial. Arch Argent Dermatol 1954;4(3):211-25.
6. Walton EW. Non-healing granulomata of the nose. J Laryngolotol 1959;73(3): 242-60.
7. Cohn AM, Park JK, Rapaportt H. Mycosis fungoides with involvment of the oral cavity. Arch Otolaryngol 1971;93(1):330-3.
8. Rappaportt H, Thomas LB. Mycosis fungoides: the pathology of extracutaneous involvement. Cancer 1974;34(4):1198-229.
9. Hood AF, Mark GL, Hunt JU. Laryngeal mycosis fungoides. Cancer 1979;43(4):1527-32.
10. Ishii Y, Yamanaka M, Ogawa K et al. Nasal T-cell lymphomas as a type of so-called lethal midline granuloma. Cancer 1982;50(11):2336-44.
11. Yamamura RT, Asada H, Mike N et al. Immunohistochemical and ultraestrutural studies on disseminated skin lesions of midline malignant reticulosis. Cancer 1986;58(6):1281-5.
12. Van Gorp J, Weiping L, Jacobse K et al. Epstein-Barr virus in nasal T-cell lymphomas in Western China. J Pathol 1994;173(2):81-7.
13. Ohno T, Yamaguchi M, Okak K et al. Frequent expression of CD3 epsilon in CD3(leu4) - negative nasal T-cell lymphomas. Leukemia 1995;9(1):44-52.
14. Aozasa K, Ohsawa M, Tomita Y et al. Polymorphic reticulosis is a neoplasm of large granular lymphocytes with CD3+ phenotype. Cancer 1995;75(3):894-901.
15. Edelson RL. Cutaneous T-cell lymphomas. Perspective. Ann Intern Med 1973;83(4):548-52.
16. Edelson RL. Cutaneous T-cell lymphoma: mycosis fungoides, Sèzary syndrome, and other variants. J Am Acad Dermatol 1980;2(1):89-106.
17. Sanchez JL, Akerman AB. The patch stage of mycosis fungoides: criteria for histologic diagnosis. Am J Dermatopathol 1979;1(1):5-26.
18. Wright JC, Gumport SL, Colomb FM. Remissions produced with the use of methotrexate in pacients with mycosis fungoides. Cancer Chemother Rep 1960;9(1):11-20.
19. Levi JA, Diggs CH, Wiernick PH. Adriamycin therapy in advanced mycosis fungoides. Cancer 1977; 39(9):1967-70.
20. Cabanillas F, Bodey GP, Freireich EJ. Management of agressive lymphoma with combination chemotherapy. Cancer 1980:46(11):2356-9.